Skip to main content

ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder

Journal of Medical Toxicology volume 18, pages 71–73 (2022)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

39,95 €

Price includes VAT (Netherlands)

References

  1. Centers for Disease Control. Overdose deaths accelerating during COVID-19. https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html. Accessed 21 Oct 2021.

  2. Bryson EO. The opioid epidemic and the current prevalence of substance use disorder in anesthesiologists. Curr Opin Anaesthesiol. 2018;31(3):388–92. https://doi.org/10.1097/ACO.0000000000000589.

    Article  PubMed  Google Scholar 

  3. Baldisseri MR. Impaired healthcare professional. Crit Care Med. 2007;35(2 Suppl):S106–16. https://doi.org/10.1097/01.CCM.0000252918.87746.96.

    Article  PubMed  Google Scholar 

  4. Federation of State Medical Boards (FSMB). Policy on physician illness and impairment: towards a model that optimizes patient safety and physician health. https://www.fsmb.org/siteassets/advocacy/policies/policy-on-physician-impairment.pdf. Accessed 21 Oct 2021.

  5. Hasin DS, O’Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834–51. https://doi.org/10.1176/appi.ajp.2013.12060782.

    Article  PubMed  PubMed Central  Google Scholar 

  6. American Society of Addiction Medicine. Definition of addiction. https://www.asam.org/Quality-Science/definition-of-addiction. Accessed 21 Oct 2021.

  7. Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, Bagley SM, Liebschutz JM, Walley AY. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137–45. https://doi.org/10.7326/M17-3107.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J, Lu L. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019;24(12):1868–83. https://doi.org/10.1038/s41380-018-0094-5.

    Article  PubMed  Google Scholar 

  9. Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. https://doi.org/10.1136/bmj.j1550.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, Gossop M. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003;326(7396):959–60. https://doi.org/10.1136/bmj.326.7396.959.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Beletsky L, Wakeman SE, Fiscella K. Opioid use disorder in physicians. Reply N Engl J Med. 2019;381(23):2281. https://doi.org/10.1056/NEJMc1913323.

    Article  PubMed  Google Scholar 

  12. Schindler SD, Ortner R, Peternell A, Eder H, Opgenoorth E, Fischer G. Maintenance therapy with synthetic opioids and driving aptitude. Eur Addict Res. 2004;10(2):80–7. https://doi.org/10.1159/000076118.

    Article  PubMed  Google Scholar 

  13. Maglione MA, Raaen L, Chen C, Azhar G, Shahidinia N, Shen M, Maksabedian E, Shanman RM, Newberry S, Hempel S. Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: a systematic review. J Subst Abuse Treat. 2018;89:28–51. https://doi.org/10.1016/j.jsat.2018.03.001.

    Article  PubMed  Google Scholar 

  14. McLellan AT, Skipper GS, Campbell M, DuPont RL. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ. 2008;337:a2038. https://doi.org/10.1136/bmj.a2038.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Beletsky L, Wakeman SE, Fiscella K. Practicing what we preach - ending physician health program bans on opioid-agonist therapy. N Engl J Med. 2019;381(9):796–8. https://doi.org/10.1056/NEJMp1907875.

    Article  PubMed  Google Scholar 

  16. Bundy C. Opioid use disorder in physicians. N Engl J Med. 2019;381(23):2280–1. https://doi.org/10.1056/NEJMc1913323.

    Article  PubMed  Google Scholar 

  17. DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. Setting the standard for recovery: physicians’ health programs. J Subst Abuse Treat. 2009;36(2):159–71. https://doi.org/10.1016/j.jsat.2008.01.004.

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Departments of Emergency Medicine & Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA

    Ryan T. Marino

  2. Department of Medical Toxicology, Banner University Medical Center Phoenix, Phoenix, AZ, USA

    Meghan Spyres

  3. University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA

    Meghan Spyres

  4. University of Rochester Medical Center, Rochester, NY, USA

    Timothy J. Wiegand

  5. Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA, USA

    Kavita M. Babu

  6. Johns Hopkins University School of Medicine, Baltimore, MD, USA

    Andrew Stolbach

Authors
  1. Ryan T. Marino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Meghan Spyres
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy J. Wiegand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kavita M. Babu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andrew Stolbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrew Stolbach.

Ethics declarations

Conflicts of Interest

None.

Disclaimer

While individual practices may differ, this is the position of the American College of Medical Toxicology (ACMT) at the time written, after a review of the issue and pertinent literature.

Additional information

Supervising Editor: Mark B. Mycyk, MD

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Marino, R.T., Spyres, M., Wiegand, T.J. et al. ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder. J. Med. Toxicol. 18, 71–73 (2022). https://doi.org/10.1007/s13181-021-00861-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-021-00861-4

Keywords

  • Opioid use disorder
  • Health care professionals
  • Physicians
  • Buprenorphine
  • Impairment